Viral Vector Manufacturing Market Insights, Trends, And Forecasts 2019-2028

Viral vector is the most effective means of gene transfer to modify specific cell type or tissue and can be manipulated to express therapeutic genes. Several virus types are currently being investigated for use to deliver genes to cells to provide either transient or permanent transgene expression. These include adenoviruses, retroviruses, poxviruses, adeno-associated viruses, baculoviruses, and herpes simplex viruses. The choice of virus for routine clinical use depends on the efficiency of transgene expression, ease of production, safety, toxicity, and stability. Furthermore, many types of viral vectors have been used in a wide array of basic and clinical studies, and genetic tools made possible to construct novel viruses intended for gene therapy, but also the development of vaccines. Moreover, in gene therapy, viral vectors can be applied to treat different diseases such as, metabolic diseases, heart defects and neurodegenerative disorders. Additionally, in vaccinology, a growing level of information supports recombinant viral vector usage as a means of vaccination. Studies have demonstrated that, when antigen-expressing viral vectors are used, the elicited T- and B-cell responses are both wider and of a greater order of magnitude than after DNA immunization alone. Owing to various applications, the Viral Vector Manufacturing market is expected to propel in near future. 

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/hc2101-viral-vector-manufacturing-market-report

VIRAL VECTOR MANUFACTURING MARKET OUTLOOK

The viral vector manufacturing market is driven by key factors such as rising prevalence of genetic disorders, cancer and infectious diseases, advancement in biotechnology, diagnostic research & pharmaceuticals and ongoing research into viral vector-based gene and cell therapies. However, huge cost associated with gene therapy and short shelf-life of viral vectors are some of the factors hampering the market growth.

VIRAL VECTOR MANUFACTURING MARKET SEGMENTAL OVERVIEW

The viral vector manufacturing market is segmented by type, disease, application, end user and geography

VIRAL VECTOR MANUFACTURING MARKET BY TYPE

Based on type, the viral vector manufacturing market is segmented into retroviral vectors, adenoviral vectors, adeno-associated viral vectors and others viral vectors. Furthermore, retroviral vectors is bifurcated into lentiviral vectors and gamma-retroviral vectors. Moreover, other viral vectors segment is sub segmented into poxviruses, baculoviruses and herpes simplex viruses. There has been a resurgence in gene therapy efforts that is partly fueled by the identification and understanding of new gene delivery vectors. Adeno-associated virus (AAV) is a non-enveloped virus that can be engineered to deliver DNA to target cells, and has attracted a significant amount of attention in the field, especially in clinical-stage experimental therapeutic strategies.

VIRAL VECTOR MANUFACTURING MARKET BY DISEASE

The disease discussed in this market are cancers, genetic disorders, infectious diseases and other. Cancer segment accounted for the largest market share in 2018. Its large share can be attributed to growing research on viral vector gene therapies for cancer.

VIRAL VECTOR MANUFACTURING MARKET BY APPLICATION

Various application are studied in this report such as gene therapy and vaccinology. Due to increase in the number of gene therapy clinical trials conducted for chronic diseases such as cancer, cardiovascular diseases, and neurodegenerative diseases globally, the viral vectors are largely used in gene therapy segment.

VIRAL VECTOR MANUFACTURING MARKET BY END USER

Based on end user, the viral vector manufacturing Market is segmented into pharmaceutical & biopharmaceutical companies and research institutes. A robust pipeline of viral vector gene therapies and successful launch of such therapies are the key factors contributing to the development of the pharmaceutical and biopharmaceutical companies segment during the forecast period.

VIRAL VECTOR MANUFACTURING MARKET BY GEOGRAPHY

Geographically, the viral vector manufacturing market is classified into North America, Europe, Asia-Pacific and Rest of the world. North America region accounted for the largest market share in viral vector manufacturing market in 2018, due to rising commercial research in personalized medicines, availability of better R&D facilities and the presence of advanced technologies. However, Asia-Pacific is anticipated to be the fastest-growing region for the viral vector manufacturing market, primarily due to the development of government policies, growing focus on research and development activities in the health care sector and rising research activities to launch novel gene therapies in this region.

VIRAL VECTOR MANUFACTURING MARKET KEY PLAYERS

Some of the major players operating in the viral vector manufacturing market includes Lonza, Merck KGaA, Oxford BioMedica Plc., Cobra Biologics, Novasep Inc., Spark Therapeutics, Kaneka Eurogentec, Finvector Vision Therapies, Brammer Bio, Cell and Gene Therapy Catapult (CGT Catapult), Fujifilm Holdings Corporation, Uniqure, Regenxbio and Massbiologics. Leading companies have invested massive capital in new product launchs, research & development and mergers & acquisitions activities to develop innovative products in the market. 

VIRAL VECTOR MANUFACTURING MARKET DEVELOPMENTS

November 2017: Lonza and Akouos, announced their strategic license agreements for exclusive rights to the ancestral adeno-associated viral vectors (Anc-AAV) gene therapy platform for all hearing and balance disorders. The agreement with Akouos is designed to accelerate AAV gene therapy for hearing and balance disorder.

April 2018: Lonza opens the world's largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies,  the next era in medicine and with the mission of enabling them to deliver these types of treatments to patients around the world more quickly and efficiently.

December 2017: Merck announced a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, USA, for its use in potentially transformative gene therapies.

Buy now Viral Vector Manufacturing Market Report https://www.axiommrc.com/buy_now/hc2101-viral-vector-manufacturing-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

                 http://contactsnleads.com/

Blog: https://industrywatch24.com/

          https://readbeyondnews.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

Comments

Post a Comment

Popular posts from this blog

Freeze Drying Equipment Market: Growth, Opportunities, and Future Outlook

Freeze Drying Equipment Market is segmented based on type, application, and region. The different types of freeze drying equipment include laboratory, pilot, and industrial-scale equipment. The applications of freeze drying equipment include food processing, pharmaceuticals, biotechnology, and others. The market is dominated by the pharmaceutical and biotechnology segments due to the high demand for freeze-dried drugs and vaccines.   Freeze drying, also known as lyophilization, is a dehydration process used to preserve perishable materials such as food, pharmaceuticals, and biologicals. Freeze drying equipment is used to carry out this process, which involves freezing the material and then removing the ice by sublimation. Freeze drying equipment is an essential tool for industries that require long-term storage of perishable materials. The global freeze drying equipment market is expected to grow at a significant rate in the coming years due to the increasing demand for freeze...
Read more

Future of Europe Infection Surveillance Solutions Market in 2022-2028

Image
Infection surveillance solutions are used to reduce several healthcare associated infections such as pneumonia (eg, ventilator-associated pneumonia [VAP]), bloodstream infection (BSI), urinary tract infection (UTI), and surgical site infection (SSI). It is also used to reduce other infections such as surgical wound infections, respiratory tract infections, and many others. A healthcare-associated infection is an infection whose development is favored by a hospital or other healthcare facilities environment, such as one acquired by a patient during a hospital visit To know the scope of our report get a sample  on https://www.axiommrc.com/request-for-sample/11021-europe-infection-surveillance-solutions-market-report MARKET DYNAMIC- EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET Primary driving factors such as the vast presence of developing as well as developed economies, increasing funding for improving the healthcare infrastructure and redevelopment of healthcare projects and s...
Read more